ERBB2 and neoplasm: Docetaxel and paclitaxel are the same type of drugs Paclitaxel and capecitabine were selected for their proven efficacy in controlling metastatic breast cancer, while trastuzumab, a monoclonal antibody targeting the HER2 receptor, was included to directly inhibit the HER2-positive tumor cells.